Korean drug makers eyes OTC market

Published: 2008-03-20 06:59:00

Updated: 2008-03-20 06:59:00

Stimulated by outer negatives affecting Korea's economy, many pharmaceutical firms plan to expand their presence in the domestic OTC market through sales push on field force and price hike.

Pharmaceutical manufactures are rolling up their sleeves to meet their annual sales target using possibl...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK